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ABSTRACT 
 
Part A of the dissertation includes the protocol of the study, which was approved by 
Faculty of Health Sciences Human Research Ethics Committee, University of Cape 
Town. The study was observational analytical, aiming to determine the magnitude and 
determinants of the ratio between prevalence of low vision and prevalence of 
blindness using Rapid Assessment of Avoidable Blindness (RAAB) surveys across 
World Bank regions. The surveys included in the study were available in the RAAB 
repository and obtained through permission from the primary investigators. A 
univariate and multivariate analysis were performed across the regions using the ratio 
as an outcome variable and potential explanatory variables as follows: prevalence of 
Uncorrected Refractive Error (URE), Cataract Surgical Coverage (CSC) at visual 
acuity 3/60, 6/60 and 6/18 for persons, logarithm of Gross Domestic Product (GDP) 
per capita and health expenditure per capita. 
Part B contains the structured literature review. PubMed, Scopus, EBSCOHOST 
(Africa wide and MEDLINE) and Web of Science databases were used to search for 
literature using the following key words: rapid assessment, blindness, age-related 
cataract, uncorrected refractive error, low vision, visual impairment, avoidable OR 
curable OR preventable OR treatable. The summary of the literature review in addition 
to the gap in the literature is presented in the section. 
Part C includes a journal manuscript, which includes methodology and results of the 
study. The main findings showed that the ratio between prevalence of low vison and 
prevalence of blindness ranged from 1.35 in Mozambique to 11.03 in India with a 
median value of 3.90. There was a statistically significant variation of the ratio across 
the regions: approximately 7.0 in South Asia and approximately 3.0 in Sub-Saharan 
Africa (χ²=28.23, p<0.001). The variables: prevalence of URE, CSC at visual acuity 
3/60, 6/60 and 6/18 for persons, logarithm of GDP per capita and logarithm of health 
expenditure per capita were found to be statistically significantly associated with the 
ratio with univariate analysis. However, only prevalence of URE and CSC at 3/60 for 
persons across the regions were found statistically significant in multivariate analysis. 
Part D comprised of appendices used in the mini-dissertation.  
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PROTOCOL SYNOPSIS 
 
Title of the study 
Magnitude and Determinants of the Ratio between Prevalences of Low vision and 
Blindness in Rapid Assessment of Avoidable Blindness Surveys 
 
Background 
A recent systematic review estimated that there were 285 million visually impaired 
people in the world: 39 million blind and 246 million low vision in 2010. People aged 
50 years and above contributed 65% and 82% of the total visual impairment and 
blindness respectively. Uncorrected refractive error (URE) (43%) and cataracts (33%) 
were the major causes of visual impairment whereas cataracts (51%) and glaucoma 
(8%) were the major causes of blindness. Cataracts are a cause of visual impairment 
as well as blindness because immature cataracts cause visual impairment whereas 
mature cataracts cause blindness. In addition, more than a billion people have poor 
vision because of lack of eye glasses and more than 100 million of them are visually 
impaired because of URE globally. It is estimated that 10% of the total URE ultimately 
causes visual impairment. 
 
The prevalence of blindness and low vision vary considerably in different 
surveys. For instance the prevalence of blindness was as little as 0.7% in Bagmati, 
Nepal to 7% in Al Amaran, Yemen. Similarly, the prevalence of low vision varied from 
2.5% in Ngozi and Kayanza, Burundi to 22.2% in Binh Dinh, Vietnam.  
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Hypothesis 
Our hypothesis is that there is a positive correlation between the ratio of prevalence 
of low vision to prevalence of blindness and the prevalence of Uncorrected Refractive 
Error in Rapid Assessment of Avoidable Blindness (RAAB) surveys. Prevalence of 
URE, which is a major cause of low vision but not of blindness, differs widely in the 
world. Therefore we expect that the variation in the ratio of low vision to blindness 
might be explained by the difference in prevalence of URE.  
 
Methodology  
Design:  Observational analytical  
Population: Rapid Assessment of Avoidable Blindness Surveys 
Sites: Worldwide 
Study duration: October 2015 to March 2016 
Instrument and methods: The ratio between prevalences of low vision and blindness 
is considered as outcome variable. Data on outcome variable along with other 
explanatory variables will be extracted from the reports which are available from RAAB 
repository website. For RAAB surveys, whose reports are not available in the 
repository, a request to send the report will be sent to the Principal Investigator of the 
survey. Univariate and Multivariate regression models will be fitted to identify the 
determinants of the variation in the ratio. 
 
Aim and Objectives 
Aim 
The aim of the study is to determine the magnitude of the ratio of prevalences of low 
vision to blindness and the determinants of the ratio in the RAAB surveys. 
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Specific objectives 
i. To describe the variation in ratios of prevalence of low vision to blindness in 
RAAB surveys across different geographical regions.  
 
ii. To measure the relationship between the outcome variable and other potential 
explanatory variables including the prevalence of Uncorrected Refractive Error, 
Cataract Surgical Coverage as a proxy for service delivery, Gross Domestic 
Product per capita and total health expenditure in the RAAB surveys. 
 
iii. To measure the correlation between the outcome variable and the prevalence 
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STUDY PROTOCOL 
 
1. PURPOSE OF THE STUDY 
The hypothesis of the study is that there is a positive correlation between the ratio of 
the prevalences of low vision to blindness and the prevalence of Uncorrected 
Refractive Error (URE) in Rapid Assessment of Avoidable Blindness (RAAB) surveys. 
The reason for this assumption is that any variation in the ratio might be due to 
difference in the prevalence of URE among populations. This is because of the fact 
that URE is more likely to cause low vision than to cause blindness. 
 
1.1 Aim and Objectives 
Aim 
The aim of the study is to determine the magnitude of the ratio of prevalences of low 
vision to blindness and the determinants of the ratio in the RAAB surveys. 
 
Specific Objectives 
i. To describe the variation in ratios of prevalence of low vision to blindness in 
RAAB surveys across different geographical regions. The ratio will be 
considered as the outcome variable.   
ii. To measure the relationship between the outcome variable and other potential 
explanatory variables including the prevalence of Uncorrected Refractive 
Errors, Cataract Surgical Coverage (CSC) as a proxy for service delivery, Gross 
Domestic Product (GDP) per capita and total health expenditure per capita in 
the RAAB surveys. 
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iii. To measure the correlation between the outcome variable and the prevalence 
of URE in RAAB surveys. 
 
2. BACKGROUND  
A systematic review estimated that there were 285 million visually impaired people in 
the world in 2010, of which 39 million were blind and 246 million were low vision.1In 
addition, more than a billion people have poor vision because of lack of eye glasses 
and more than 100 million of them are visually impaired because of Uncorrected 
Refractive Error globally.2  It is estimated that there are 1 to 2 billion people with URE 
in the world. The figure on URE was projected from the findings of the Blue Mountain 
Eye Study (BMES) in Australia which showed that prevalence of URE is 10 times 
larger than the prevalence of visual impairment caused by URE.3 It is important to note 
that the BMES study defined URE as any amount of refractive error which could be 
corrected with spectacles but had not been. However, blindness surveys such as 
RAAB surveys defined URE as refractive error which improves from visual acuity of 
less than 6/60 to at least 6/18 with the pinhole test. 
 
According to the International Classification of Diseases (ICD)-10th revision4, 
blindness is defined as visual acuity of less than 3/60. Moderate Visual Impairment 
(MVI) is defined as visual acuity of less than 6/18 but equal to or better than 6/60 and 
Severe Visual Impairment (SVI) is defined as visual acuity of less than 6/60 but equal 
to or better than 3/60. All acuities are of the available correction in the better eye. In 
addition, MVI and SVI are jointly called low vision. It is essential to note that in the field 
of vision rehabilitation, the term “low vision” refers to people who have had medical, 
spectacle, and surgical  corrections and still have vision less than 6/18 but better than 
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light perception. In this study, low vision will be used as the ICD-10 definition. 
Furthermore, it is worth noting that none of the definitions mentioned above account 
for visual acuity for near visual tasks.  
 
Globally, cataracts (51%) and glaucoma (8%) are the major causes of blindness 
whereas Uncorrected Refractive Error (43%) and cataracts (33%) are the major 
causes of visual impairment.1 Cataracts are a cause of visual impairment as well as 
blindness because immature cataracts cause visual impairment whereas mature 
cataracts cause blindness. It was found that people aged 50 years and above 
contributed 65% and 82% of the total populations of visual impaired and blind people 
respectively in the world.  
 
Until 2005, Rapid Assessment of Cataract Surgical Services (RACSS) survey 
was used to assess blindness and visual impairment in Asia, Africa and Latin 
America.5, 6 RACSS surveys use multistage cluster sampling to select the participants. 
Within a cluster, the households are selected by the “random walk” method in which 
households are chosen based on the orientation of the neck of a spun bottle at every 
crossing of the streets. People of age 50 years and above living in the house are 
interviewed with the questionnaire as well as examined for vision loss. However, there 
are mainly two limitations of the RACSS survey method.7 Firstly, as the selection of 
households for the eye examination is done using the random walk method, which 
involves an individual’s subjective decision to choose the house to be included in the 
survey, it is likely to yield selection bias particularly in larger populations. Secondly the 
RACSS survey does not account for other causes of vision loss besides cataracts.  
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Rapid Assessment of Avoidable Blindness (RAAB) methodology was 
developed after a national blindness survey conducted in the Gambia in 1996. The 
national eye survey was performed to estimate the prevalence and distribution of 
visual impairment and blindness.8 The results of the countrywide survey were 
compared with another survey which was conducted among people of age 50 years 
and above.9 The comparison showed that the causes of blindness and visual 
impairment among the 50 years and above group was a good indicator of the causes 
in the total population. Furthermore, the distribution of causes of severe visual 
impairment and moderate visual impairment was similar in both groups except for 
refractive error, which was proportionally more important in the total population than 
in the 50 years and above.9 
 
Essentially, RAAB is an upgraded and revised version of the RACSS.5 RAAB 
provides more standardised methodology and training for examiners so the results are 
easily comparable across different surveys.9 Unlike RACSS, RAAB uses the “compact 
segment” sampling method which is a random selection of a segment of the population 
as a cluster and includes all the households of that segment. The people of age 50 
years and above in the households undergo visual acuity measurement, pinhole acuity 
assessment if the visual acuity is less than 6/18 and ocular examination with torchlight 
and direct ophthalmoscope. The improvement of visual acuity with pinhole is 
considered as a proxy for the presence of refractive error.7 The primary focus of RAAB 
is on the prevalence of major causes of avoidable blindness, which are: blindness due 
to cataracts, refractive errors, trachoma, onchocerciasis, corneal scarring and 
posterior segment diseases such as glaucoma. This is in line with the aim of “VISION 
2020: The Right to Sight”, which aims to eliminate avoidable blindness by the year 
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2020.10 Furthermore, RAAB surveys are helpful in assessing CSC, identifying the main 
barriers to the uptake of cataract surgery and measuring the outcome after cataract 
surgery.10 
 
Despite many advantages, RAAB surveys have some limitations. Because the 
eye examination is conducted door-to-door, the diagnostic facilities are limited. 
Therefore the exact cause of loss of vision may not be identified for posterior segment 
diseases such as glaucoma or diabetic retinopathy. Moreover, RAAB only includes 
people aged 50 years and above, therefore the prevalence of blindness in people 
under 50 years cannot be estimated. In addition, RAAB measures only blindness or 
visual impairment and does not assess other non-vision impairing conditions such as 
active trachoma, trichiasis and onchocerciasis.10   It also does not assess early signs 
of serious eye diseases such as glaucoma which may be present but not yet have 
caused severe vision loss in an individual. 
 
The results of the RAAB surveys along with RACSS surveys are available freely 
in the RAAB repository website (http://www.raabdata.info/repository/). The purpose of 
the repository is to bring the survey findings in to public access so that interested 
researchers can utilise them easily. The RAAB repository displays summary tables 
which provide data on sample size, coverage of the survey, proportion of total 
blindness and low vision and proportion of blindness related to cataract, refractive 
error and diabetic retinopathy. Similarly, CSC, outcome of cataract surgeries and 
proportion of intraocular lens insertion are available in the summary. Furthermore, 
some of the full reports of the surveys are available in the RAAB repository website 
while others can be requested from the principal investigators through a built-in 
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request form within the website. The links to the relevant publications of the surveys 
are also available in the website.  
 
Comparison of the survey results show that there is a big variation of 
prevalence of blindness and low vision across the regions. A recent systematic review 
found that prevalence of blindness varies from 0.1% in Uganda to 9% in Eritrea among 
Sub-Saharan African countries.11 The variation of prevalence of blindness was 
narrower in Latin American countries which ranged from 1.3% in Argentina to 4% in 
Peru.7 Similarly, prevalence of low vision varied from 1.6% in Gambia and Uganda to 
17.1% in Ghana in Sub-Saharan Africa whereas the variation was 5.9% in Argentina 
to 12.5% in Peru in  Latin America.7, 11 
 
There is a broad agreement that cataracts and refractive errors are the leading 
causes of blindness and visual impairment, hence they should be the priority diseases 
for VISION 2020 programs. The simplest way to reduce blindness and visual 
impairment related to cataracts is by performing as many cataract surgeries as 
possible with good visual outcomes. If Cataract Surgery Rate (CSR), which is the 
number of cataract operations performed in a year per one million of the population, 
is high, we can assume that the CSC will be high too. Cataract Surgical Coverage, 
which is defined as the proportion of people who received surgery among those who 
required it, is the indicator used to measure the extent of the cataract surgical need.12 
However, the CSR is dependent upon many factors such as age structure of the 
population particularly the proportion of people over 50 years of age, visual acuity 
threshold at which cataract operation is set to be performed and accessibility and 
affordability of the cataract surgery.13 
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Uncorrected Refractive Error is not only the leading cause of visual impairment, 
but also a major cause of disability globally which hugely reduces economic 
productivity and educational opportunities as well as overall quality of life.2, 14 Even 
though provision of eye glasses is a simple, effective and largely affordable remedy 
for URE, the majority of people do not benefit from spectacles in low resource settings. 
The main barriers identified are awareness about the services, accessibility of the 
services and affordability of the spectacles.2 This shows that there is some relationship 
between visual impairment and the economic status of the country.  
 
In addition, it is found that the prevalence of blindness is associated with the 
economy of the country. For instance, the estimated prevalence of blindness is 0.25% 
in high income countries, whereas the prevalences are 0.50%, 0.75% and more than 
1.0% in middle, low and very low income countries respectively.15 
 
The World Health Organization (WHO) estimated the prevalence of low vision 
based on the prevalence of blindness for the VISION 2020 programs. For adults, the 
prevalence of low vision is estimated to be three to four times the prevalence of 
blindness. However, a study of 27 RAAB surveys in 19 Sub-Saharan African countries 
found that the ratio between the prevalences of low vision and blindness varied from 
1.3 to 6.3.16 The study recommended further research to explore the determinants of 
the wide variation.  
 
To the best of our knowledge, there is no evidence on the distribution of the 
ratio of prevalences of low vision to blindness in other geographical regions. Therefore, 
this study is proposed to find the magnitude and the determinants of the ratio between 
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prevalence of low vision and prevalence of blindness in all the RAAB surveys. 
Describing the variation among a larger number of surveys from a wider geographical 
area and examining whether it is correlated with the prevalence of URE would 
enhance understanding of the epidemiology of visual impairment and blindness 
globally and possibly provide a useful indicator for where URE needs to be targeted.  
 
3. METHODOLOGY 
3.1 Study Design 
The study design will be observational analytical. A retrospective secondary analysis 
of cross-sectional survey data will be performed from the previously performed 
population based RAAB studies.  A pilot study will be conducted including 10 RAAB 
surveys to validate the data collection tools. 
 
3.2 Sample Size  
In order to calculate a sample size we considered the question of whether the 
correlation coefficient between the outcome variable (ratio) and the prevalence of URE 
in the populations differs from zero.  We wanted to show a correlation coefficient (r) of 
0.3 and we used the formula below.17 
N= [(Zα +Zβ) ÷C] 2 +3 
where  
r= expected correlation coefficient 
C=0.5 X ln [(1+r) / (1-r)] 
N=Total number of subjects required 
For a β of 0.2 and a two sided α of 0.01, the sample size we need would be 67 studies. 
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Out of a total of 156 RAAB surveys available in the repository website (as of 10 
February, 2016), the reports for 66 surveys are downloadable. The request to send 
the reports will be sent to 90 remaining surveys using the request report link of the 
repository. The surveys which meet the inclusion criteria and have accessible full 
reports will be included in the study.  
 
3.3 Inclusion Criteria 
RAAB survey will be included in the study if;  
o The coverage of the primary survey was at least 80% of the sample size selected. 
o The standard RAAB reports are available in the website or the reports are received 
through a built in “Request Report” feature of the website. 
 
3.4 Exclusion Criteria 
o If there is more than one survey conducted for the same region, the latest survey 
will be used for the analysis. 
o Surveys which have missing data for the study variables.  
 
3.5 Research Procedures and Data Collection Methods 
All RAAB surveys follow the standard RAAB examination methodology. Each 
participant undergoes eye examination in each eye with visual acuity graded into 6 
categorises (≥6/18 to no light perception). Visual acuity is measured using a Snellen 
tumbling ’E’ chart with an optotype of size 6/18 and 6/36 on either side at 6 metres (or 
3 metres distance if required) in daylight with best available correction. When 
presenting visual acuity is less than 6/18 in either eye, visual acuity is measured with 
a pinhole. Primary cause of visual impairment is recorded as refractive error if the 
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visual acuity improved to at least 6/18 with a pinhole. In cases in which visual acuity 
does not improve with a pin-hole, further examination is performed by an 
ophthalmologist or ophthalmic clinical officer.   
 
Whenever multiple causes of visual impairment are observed, the most 
treatable or preventable condition is recorded as the primary cause of vision loss. For 
example if a person has refractive error and cataract, refractive error is recorded as 
the primary cause. Similarly if a person has cataract and glaucoma, cataract is 
recorded as the primary cause. The RAAB data are initially recorded on standard 
forms before being transferred into RAAB software (version 4.02 software, 2007, 
International Centre for Eye Health, UK). Crude, age-adjusted prevalences and 
causes of blindness and visual impairment are calculated using the RAAB software. 
All completed RAAB survey results are made available on the RAAB repository 
website; http://www.raabdata.info/repository/.  
 
The Principal Investigator (PI) will assess the eligibility criteria of 156 RAAB 
surveys. The surveys which meet the inclusion criteria will be identified using the 
inclusion criteria checklist (Appendix 1). The full reports of the identified surveys will 
be downloaded, if available from the website. For reports which are not available 
online, a request for the report will be sent to the PI of the survey via the built in link of 
the website. A second reminder request will be sent if the report is not received within 
a month. If the report is not received within two weeks of the reminder the study will 
be excluded from the analysis.   
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The relevant data such as prevalence of low vision and blindness, prevalence 
of URE and CSC for persons at 3/60, 6/60 and 6/18 will be extracted from the RAAB 
reports before entering them in the data capture sheet. The data on GDP per capita 
and health expenditure per capita of the countries will be obtained from the World 
Bank website for the year the survey was conducted or the closest year available.18, 19 
Additional data to be extracted from the standard RAAB reports are shown in the data 
capture sheet (Appendix 2).The regions for the data analysis will be classified based 
on the World Bank classification; Sub-Saharan Africa, South Asia, Latin America and 
Caribbean, East Asia and Pacific, Middle East and North Africa, Europe and Central 
Asia and North America.20 
 
3.6 Data Analysis 
The data will be initially entered in a Microsoft Excel 2013 data sheet, then it will be 
transferred to data analysis statistical software STATA 11 (Stata Corp. College 
Station, Texas) for analysis. The ratio of the prevalences of low vision to blindness will 
be calculated for each survey, then it will be described as either mean (with confidence 
intervals) or median (with interquartile range) based on the normality test. The 
relationship between the ratios and the prevalence of URE in the population will be 
calculated by using Pearson’s or Spearman’s correlation test, based on the normality 
of the ratio. The distribution of the ratios across the geographical regions will be 
assessed by using the Analysis of Variance (ANOVA) test. The effect of other 
explanatory variables (such as CSC at different visual acuity levels for persons, GDP 
per capita and total health expenditure per capita) on the magnitude of ratios will be 
explored by using univariate regression analysis. The explanatory variables which 
were found to have p value below 0.2 in univariate analysis will be included for 
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multivariate analysis. The significance level will be considered at 5% for two tailed 
tests. The description and source of the variables is presented in Table 1.  
 
3.7 Ethical Approval 
The ethical approval of the study protocol will be obtained from the University of Cape 
Town Departmental Research Committee and the Faculty of Human Research Ethics 
Committee. As a part of the standard methodology of RAAB surveys, all RAAB surveys 
obtained ethical approval from the relevant ethics committee of the respective region 
or province.  Participants who were enrolled in the surveys provided verbal consent 
for the study.  Each individual survey was conducted in accordance with the tenants 
of the Declaration of Helsinki.  In addition, this study will also adhere to the ethical 
principles of the Declaration of Helsinki. 
 
3.8 Risks 
The primary RAAB surveys pose minimal risk to the participants. This research will 
utilise the data from the previously conducted surveys, therefore it will not have any 
harmful effects on the human subjects.  
 
3.9 Potential Benefits 
The major benefit of the primary RAAB surveys was to measure the prevalence and 
the causes of blindness and visual impairment in different surveyed regions. This could 
benefit the population by targeting resources towards the more prevalent conditions. 
The current study will identify the magnitude and the determinants of the ratio between 
visual impairment and blindness in different regions which will be useful to prioritise 
the activities of VISION 2020 programs. 
   
Part A: Protocol 19 
Table 1. Description and source of the variables. 
 
LV, Low Vision; BL, Blindness; URE, Uncorrected Refractive Error; MVI, Moderate 
Visual Impairment; SVI, Severe Visual Impairment; CSC, Cataract Surgical Coverage; 
WB, World Bank; GDP, Gross Domestic Product. 
Variables Description and source 
Prevalence of 
unadjusted LV 
Continuous variable, obtained from Sample report (Table 2) 
Prevalence of 
unadjusted BL 
Continuous variable, obtained from Sample report (Table 2) 
Ratio  Ratio of the prevalence of unadjusted LV to the prevalence of 
unadjusted BL 
Prevalence of URE Continuous variable, calculated as the number of people Blind, SVI 
and MVI due to URE  divided by  the total number of  people 
examined in the survey: obtained from Sample report (Tables 1, 4, 
6 & 8) 
CSC 3/60 (Persons) Continuous variable, obtained from Sample report (Table 12)  
CSC 6/60 (Persons) Continuous variable, obtained from Sample report (Table 12) 
CSC 6/18 (Persons) Continuous variable, obtained from  Sample report (Table 12) 
WB region Polytomous variable: 6 regions based on World Bank 
classification20 
GDP per capita GDP per capita in US dollars by country for closest year of survey, 
obtained from WB report18 
Health expenditure 
per capita 
Health expenditure per capita in US dollars by country for closest 
year of survey, obtained from WB report19 
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3.10 Informed Consent  
The participants of the primary RAAB surveys provided verbal informed consent. As 
this study utilises the data from the previous surveys, there will not be any informed 
consent process.  
 
3.11 Privacy and Confidentiality  
The extracted data for the study will be kept in a password protected computer file of 
the primary investigator to maintain privacy and confidentiality. The data will be 
destroyed after 5 years of the completion of the study. 
 
3.12 Dissemination of the Results 
This study is a part of the mini-dissertation for the Masters of Public Health, Community 
Eye Health track at University of Cape Town. A copy of the dissertation will be made 
available at the Health Sciences library. In addition, as a part of the dissertation, a 
manuscript describing the study and the findings of the study will be prepared for a 




The timeline for the dissertation work is shown in Table 2. 
 
Budget and Costs 
There was no major cost involved for the dissertation as the secondary data was 
collected from online sources. 
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Table 2. Timeline of dissertation. 
Task Oct-Nov’15 Dec’15 Jan’16 Feb’16 Mar’16 
Protocol development      
DRC Application      
Structured literature review      
HREC application      
Manuscript preparation      
Submission of dissertation      
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1. SUMMARY 
There are 32.4 million blind and 191 million moderate and severe visually impaired 
people in the world. These data come from a systematic review which included the 
results of Rapid Assessment of Avoidable Blindness (RAAB) surveys and Rapid 
Assessment of Cataract Surgical Services (RACSS) in addition to unpublished 
population based surveys.  
 
The prevalence of blindness and low vision (low vision includes moderate and severe 
visual impairment) is found to vary greatly among the surveys. For “VISION 2020: The 
Right to Sight initiative”, it is generally estimated that the prevalence of low vision is 3 
to 4 times that of blindness. However this estimate is not applicable for all regions. For 
instance, it was found that the ratio between the proportion of low vision and the 
proportion of blindness in the population varies from 1.30 to 6.30 in Sub-Saharan 
Africa. Moreover, there is no evidence for the magnitude of the ratio in other continents 
or for the determining factors for the ratio. Therefore we proposed a study to describe 
the magnitude of the ratio in different regions as well as to identify the contributing 
factors determining the ratio. Our assumption is that prevalence of Uncorrected 
Refractive Error (URE) could possibly explain the variation in the ratio since this is the 
main cause of severe and moderate visual impairment but not of blindness. 
Understanding the factors contributing to the variation would help to prioritise the 
ophthalmic services since the provision of spectacles to the people with URE is 
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2. AIM OF THE LITERATURE REVIEW 
The aim of the literature review was to identify indexed articles which could provide 
the magnitude of the prevalences of low vision and of blindness in RAAB surveys and 
potentially explore the variation of ratio of prevalences of low vision and of blindness 
in RAAB surveys across different regions. 
 
3. STUDY QUESTION 
What is the variation of the ratio between prevalence of low vision and prevalence of 
blindness in the RAAB surveys?  
What are the determining factors for the variation of the ratio between prevalence of 
low vision and prevalence of blindness? 
 
4. LITERATURE SEARCH STRATEGY 
4.1 Inclusion and Exclusion Criteria 
Inclusion Criteria  
Studies which used population based Rapid Assessment of Avoidable Blindness 
survey methodology. 
Studies which provided the data on prevalence of low vision and prevalence of 
blindness. 
Studies which had at least 80% of coverage of the sample size. 
 
Exclusion Criteria 
Surveys which used methodology of RACSS and custom surveys. 
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4.2 Quality of Literature 
Population based cross-sectional surveys which used multistage cluster sampling, 
which is one of the proportional probability sampling techniques for data collection 
were included in the study.  
 
4.3 Databases 
The literature was searched using the following databases; MEDLINE (through 
PubMed), Embase (through Scopus), EBSCO-host (selecting Africa-Wide Information 
and MEDLINE) and Web of Science for the articles listed before 8 February 2016 in 
the database.  For PubMed, articles were filtered using only “Human species”. English 
language was used for all the databases to filter the publications. There was no filter 
on the article type, text availability and publication dates. 
 
4.4 Keywords 
The following keywords were used for the literature search; rapid assessment, 
blindness, age-related cataract, uncorrected refractive error, low vision, visual 
impairment, avoidable, preventable, curable, treatable. 
 
Out of 192 articles identified using the PubMed search, 7 articles were found relevant 
to our study and were selected for this literature review. We also searched the 
reference list of the included articles using the “snow ball technique”. The keywords 
and number of studies found in PubMed is shown in Table 1. 
 
The same keywords were used with minor modification for the other databases 
according to the requirements of the databases. Three more articles were found 
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through EBSCO-host and one more article was found through Web of Science which 
had not been found through PubMed. There were no more articles found through 
Scopus than through PubMed.  
 
Table 1. Keywords and number of studies found in PubMed. 
 Keywords Studies found 
1 Rapid assessment 15,981 
2 Blindness 25,599 
3 Age-related cataract 1806 
4 Uncorrected refractive error 2688 
5 Low vision 10468 
6 Visual impairment 61406 
7 #2 OR #3 OR #4 OR #5 OR #6 77,403 
8 Avoidable OR curable OR preventable OR treatable 33,571 
9 #1 AND #7 AND #8 192 
 
 
5. LITERATURE REVIEW 
5.1 Definition of Blindness and Low Vision 
Many ophthalmic surveys, including RAAB surveys, use the World Health 
Organization (WHO) International Classification of Diseases 10th edition definition of 
blindness and low vision but with some small modification. This is to include people 
with uncorrected aphakia and Uncorrected Refractive Error in the definition.1 Blindness 
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is defined as Presenting Visual Acuity (PVA) of less than 3/60 in the better eye 
whereas low vision is defined as PVA of less than 6/18 but not less than 3/60 in the 
better eye. Recently the WHO replaced the term low vision with Moderate Visual 
Impairment (Category 1: PVA worse than 6/18 and equal to or better than 6/60) and 
Severe Visual Impairment (Category 2: PVA worse than 6/60 and equal to or better 
than 3/60).1 
 
5.2 Epidemiology of Blindness and Visual Impairment 
Globally, there are 32.4 million blind and 191 million moderate and severe visually 
impaired people.2 It is important to note that these figures are lower than in the global 
estimates of visual impairment study.3 Since the estimates of the global burden of 
disease study came from more recent and larger published, as well as unpublished, 
studies we preferred to use them consistently for the remaining sections of the study.  
Worldwide, cataracts (33%) are the leading cause of blindness followed by URE (21%) 
and macular degeneration (7%). There are some variations in the causes of blindness 
across different regions. Cataracts are the main (>40%) cause of blindness in South 
and Southeast Asia, Oceania and Sub-Saharan Africa whereas macular degeneration 
is the leading (>15%) cause of blindness in high income regions, Southern Latin 
America and Central and Eastern Europe.  
 
Uncorrected Refractive Error (53%) is the leading cause of Moderate and 
Severe Visual Impairment (MSVI) followed by cataracts (18%) and macular 
degeneration (2%) globally.2 In 2010, people affected by blindness and MSVI caused 
by URE were 6.8 (95% Confidence Intervals, CI 4.7-8.8) million and 101.2 (95% CI 
87.88; 125.5) million respectively. Furthermore, the age-adjusted combined 
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prevalence of URE causing blindness and MSVI in adults was 5.7% (95% CI 5.0-
6.9%). Similarly, the proportion of MSVI related to cataracts is smallest in the highest-
income regions (Range 13.0 to 13.8%) and largest in South Asia (21.4%, 95% CI 16.1-
24.2) and Southeast Asia (22.7%, 95% CI 17.9; 27.4). 
 
It is important to note that nearly two-thirds (65%, 95% CI, 61-68) of blindness 
and just over three-quarters (76%, 95% CI 73-79) of MSVI is preventable or treatable. 
These data come from a systematic review which included 48 population-based 
unpublished studies, 4 government reports and 44 rapid assessment surveys 
particularly; Rapid Assessment of Cataract Surgical Services surveys and Rapid 
Assessment of Avoidable Blindness surveys.  
 
5.3 Rapid Assessment Methods in Eye Care 
Studies from various parts of the world have shown that visual impairment affects the 
quality of life of individuals.4-6 Quality of life can be improved greatly if avoidable 
blindness is eliminated. The WHO along with International Agency for the Prevention 
of Blindness (IAPB) introduced an initiative, “VISION 2020: The Right to Sight”,  with 
the goal to eliminate avoidable blindness by the year 2020.7 The VISION 2020 initiative 
initially prioritises five areas based on the magnitude of the problem and cost-effective 
treatment options. The priority areas are cataract, trachoma, onchocerciasis, 
childhood blindness and refractive errors and low vision.  
 
In order to find out the prevalence of low vision and blindness in the populations 
of different countries surveys had to be conducted. Traditional epidemiological surveys 
provide accurate information however they are heavily constrained by money and time 
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particularly in resources limited settings. To overcome this challenge, Rapid 
Assessment (RA) methods have been developed. RA methods were used in the 1990s 
in eye care for cataract, onchocerciasis and trachoma and more recently in avoidable 
blindness and visual impairment.8 The main advantageous features of RA methods 
are: use of local resources, simplified sampling methodology and simple examination 
and data collection protocol which can be conducted by locally available human 
resources.9 The survey is relatively inexpensive so it can be repeated every 5 to 10 
years to assess the change of disease burden or to evaluate the impact of an 
interventional program.  
 
Rapid Assessment methods have been used to provide  global information on 
blindness and its causes for populations aged 50 years and above in order to plan for 
VISION 2020 programmes and to monitor progress towards the VISION 2020 goal.9 
The information obtained from samples of people ≥ 50 years of age can be used to 
estimate the prevalence in the total population since we expect that at least 80% of 
blindness is found in the population ≥ 50 years.10, 11 Rapid Assessment of Cataract 
Surgical Services and Rapid Assessment of Avoidable Blindness are the two widely 
used RA methods in eye care.  
 
5.3.1 Rapid Assessment of Cataract Surgical Services 
Rapid Assessment of Cataract Surgical Services (RACSS) was one of the earliest RA 
methods. It was used to find out information about the age group 50 years and above 
on the prevalence of blindness due to cataracts, Cataract Surgical Coverage, visual 
outcomes after cataract surgery and barriers for uptake of cataract surgery.12 It was 
the first standardised method proposed to measure vision loss and was used until 
                                                                                                                                                    
Part B: Structured Literature Review 10 
2005.  RACSS uses Expanded Programme on Immunization (EPI) random walk 
cluster sampling method.   
 
Expanded Programme on Immunization random walk sampling method divides 
the study area into clusters with a comparable number of households and average 
number of people in each household based on the recent census data. The clusters 
to sample, usually of 40 to 50 households, are then randomly selected.13, 14 The second 
stage of the sampling is selection of individual households within the cluster. It is 
recommended to start the selection process at the centre of the area, which is 
identified as a cluster. One direction is randomly selected at the centre of the cluster, 
usually by spinning a bottle and starting with the first household where the neck of the 
bottle faces. The adjacent household with the closest door is selected as the second 
household and so on. This process carries on until the last household to be sampled 
from that cluster is visited. 
 
Despite wide use of the EPI random walk sampling method it has several 
limitations. Firstly, clusters are divided based on the population proportion to size 
which comes from the census. Unfortunately, census data may not be accurate and 
updated in many low and middle income countries. In addition a census conducted 
every ten years may not reflect the true population changes and growth rates.  
Secondly, the first household within the cluster is selected based on the spun bottle 
which is a subjective method, the EPI sampling method is likely to have selection bias. 
Moreover, the centrally located households may be systematically different from 
peripherally located households, potentially creating selection bias. For example, 
households with common features such as higher family income are likely to be 
                                                                                                                                                    
Part B: Structured Literature Review 11 
adjacently located. Taking into account design effect is expected to minimise these 
biases but cannot eliminate them completely.  
 
The RACSS eye examination protocol comprises of visual acuity measurement 
using the modified Snellen tumbling E chart with 6/60 and 6/18 optotype on either side. 
The crystalline lens is examined using a torchlight and direct ophthalmoscope and the 
fundus is examined by direct ophthalmoscopy. Participants with visual acuity below 
6/18 in either eye are referred to the nearest eye care facility for further investigation 
or treatment.   
 
RACSS software is available to assist at all stages of the survey: sample 
selection, data entry and automated data analysis. The software is designed to 
perform the survey easily without the need of experts such as statisticians. 
 
5.3.2 Rapid Assessment of Avoidable Blindness 
Rapid Assessment of Avoidable Blindness is essentially a modified, and improved 
version of RACSS, commonly used from 2005 onwards.12 RAAB provides information 
on the prevalence of visual impairment due to avoidable and correctable causes such 
as cataracts, URE, glaucoma, trachoma, onchocerciasis and corneal scarring. Like 
RACSS, it also provides data on CSC, barriers to the uptake of cataract surgery and 
visual outcome after surgery. RAAB uses compact segment sampling methods to 
recruit  2000 to 5000 participants of age 50 years and above, typically at district level.15 
 
Compact segment sampling method is the improved version of cluster sampling 
method  introduced to overcome the limitations of the EPI method.16 The first stage of 
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the sampling is the determination of sample size followed by selection of cluster based 
on the population proportion to size method. In the second stage sampling a map of 
the study clusters is divided into segments with an equal number of individuals in each 
segment, usually 50 people of ≥50 years of age. A segment is randomly selected from 
each cluster and all the households of the segment included for the survey.  All eligible 
people in that segment are examined similar to in RACSS methodology except that 
the fundus is examined by direct ophthalmoscopy through the pupil which may be 
dilated at the discretion of the examiner.   
 
Unlike in EPI random walk method, compact segment sampling method 
eliminates the subjectivity while selecting the first household thus minimising possible 
bias from household selection. Moreover, this sampling method recommends to  revisit 
the households when there is no response.16 There is a standardised training package 
for RAAB surveys, which can be conducted only under the supervision of certified 
RAAB trainers. Inter-observer variation is measured among the teams to maintain the 
uniformity before the survey.  A kappa score of 0.6, which is considered to be a 
moderate strength of inter-observer agreement, is required for a RAAB survey to be 
valid.17 
 
Even though RAAB overcomes some of the limitations of RACSS, it still has 
some drawbacks. Diagnosis of posterior segment diseases using the direct 
ophthalmoscope may not be very accurate and the procedure is difficult to do properly 
in the field situation. Moreover, leaving dilation of the pupil to the discretion of the 
examiner means that some examinations are performed more thoroughly than others. 
Similarly, URE is defined as inability to see 6/60 but can see 6/18 when pinhole is 
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used. This diagnosis guideline provides a gross estimate of refractive error but cannot 
provide information on the severity of the refractive error.   
  
One problem with both RACSS and RAAB surveys is that only the most easily 
preventable or curable cause of blindness or visual impairment is reported while in 
reality there are often multiple causes contributing equally to the vision loss. For 
example this potentially underestimates the impact of diabetic retinopathy, glaucoma 
and other diseases when a patient presents with cataract.18 Recently, examination to 
detect Diabetic Retinopathy (DR) has been added to the RAAB methodology, which 
is also referred to as RAAB+DR.  
 
The major strength of the RAAB is its standardised methodology. Although it is 
not perfect, it allows the best possible opportunity to make comparisons of the 
prevalence of vision loss and the causes of the vision loss across different settings. 
 
5.4 Rapid Assessment of Avoidable Blindness Repository  
The RAAB repository provides safe storage of the results of RACSS and RAAB 
surveys conducted worldwide (http://www.raabdata.info/repository/). The freely 
available RAAB software assists in sample selection, data entry and data analysis. All 
results are presented in a standardised format using the RAAB software. Full reports 
of the surveys are either available from the repository or may be requested from the 
Principal Investigator (PI). The main aim of freely sharing the information to the public 
is that researchers can have easy access to the data for study purposes. However, 
the PI or the donor agency determines what information to put in the repository and 
what information to provide on request.19 This makes it difficult to generalise the 
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findings locally or globally merely based on the repository results. If more survey 
results were available in the repository then accessing a proper representation of 
results would be easier.  
 
5.5 Variation of the Prevalences of Blindness and Visual Impairment  
The prevalences of blindness and low vision vary greatly among the RAAB surveys. 
For instance a recent systematic review in Sub-Saharan Africa (SSA), which included 
17 surveys of 15 counties, found that the prevalence of blindness ranged from 0.1% 
in Uganda to 9% in Eritrea.20 In addition, the prevalence of low vision varied from 1.6% 
in Gambia and Uganda to 17.1% in Ghana. Similarly a recent review study conducted 
using RACSS and RAAB surveys of 12 Latin American countries found that the 
prevalence of blindness was between 1.3% in Argentina and 4.2% (PVA <6/60 in the 
better eye) in Venezuela.21 A previous review of 9 surveys from Latin America found  
the prevalence of blindness similar to that found in the recent review (1.3% in 
Argentina and 4% in Peru) whereas the prevalence of low vision was found to be 
between 5.9% (in Argentina) and 12.5% (in Guatemala).10 The wide variation in the 
prevalences of low vision and blindness in different countries has to be considered in 
order to allocate resources appropriately. 
 
5.6 Potential Determining Factors of the Ratio  
In order to achieve the goal of VISION 2020, priority has to be given to cataracts and 
URE which are the leading causes of blindness and visual impairment respectively. 
The simplest way to reduce the visual impairment and blindness related to cataracts 
is to perform as many cataract surgeries as possible. By increasing the Cataract 
Surgical Rate (CSR), which is the number of cataract surgeries per million population, 
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we can increase CSC. Cataract Surgical Coverage, which is the proportion of people 
who had the surgery among those who needed it, is considered an indicator to 
measure what extent of the cataract surgical need is met for a community.22 However, 
CSR is dependent upon  many other factors such as population structure, particularly 
elderly population, visual acuity threshold for the surgery and accessibility and 
affordability of the cataract surgical services.23 
 
One of the most important potential determining factors for the ratio of low vision 
to blindness is URE. The simplest way to reduce visual impairment and blindness 
caused by URE is to identify the refractive errors and provide the appropriate refractive 
correction, commonly spectacles. When refractive errors are not corrected, as with 
other disabilities, they reduce economic productivity and educational opportunities as 
well as quality of life.24, 25 Even though provision of spectacles is a simple, effective, 
and largely affordable management for URE, the majority of people do not get 
spectacles in low resource settings. The main barriers identified for this are awareness 
about the services, accessibility of the services and affordability of the spectacles.24 
Since accessibility and affordability of ophthalmic services are the barriers to spectacle 
provision, it is likely that there is some relationship between URE and the economic 
status of a country. 
 
It is interesting to note that the prevalence of blindness varies with the country’s 
economy. For instance it is estimated that the prevalence of blindness is more than 
1% in very low income countries whereas it is 0.75%, 0.50% and 0.25% in low, middle 
and high income countries respectively.26 
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Since the data on low vision prevalence is not available for many regions, 
prevalence of low vision is estimated based on the prevalence of blindness: it is 
estimated to be 3 to 4 times the prevalence of blindness in adults.26 However, there is 
a wide variation in the ratio of prevalence of low vision to prevalence of blindness 
worldwide.  For example the ratio of the prevalence of low vision to blindness was 
found to be between 1.3 and 6.3 in 27 RAAB surveys of 19 Sub-Saharan African 
countries.27 To understand the variation better, Lewallen et al. recommended further 
research which identifies the determining factors of the ratio.27 
 
5.7 Identification of the Gap  
To the best of our knowledge, there is no description of the variation of ratio of 
prevalence of low vision to blindness in countries other than in Sub-Saharan Africa, 
nor is there any exploration into the reasons for the variation. It was found from the 
previous review that URE is the most common cause of low vision but is not a common 
cause of blindness.28 Since the prevalence of refractive errors vary tremendously in 
various parts of the world 24, 25, 28 it is possible that variation in URE would explain the 
variation in the ratio of prevalence of low vision to prevalence of blindness.  Describing 
the variation across a large number of surveys from a wide geographical region and 
examining whether it is associated with prevalence of URE would enhance 
understanding of epidemiology of visual impairment and blindness globally and 
possibly provide useful information for predicting the impact of targeting URE needs. 
Therefore this study was proposed to determine the magnitude and the determinants 
of the ratio between prevalence of low vision and prevalence of blindness globally, 
using data from RAAB surveys.   
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ORIGINAL ARTICLE  
Magnitude and Determinants of the Ratio between Prevalences of 








Purpose: To determine the magnitude and determinants of the ratio between 
prevalence of low vision and prevalence of blindness in Rapid Assessment of 
Avoidable Blindness (RAAB) surveys globally. 
Methods: Standard RAAB reports were downloaded from the repository or requested 
from principal investigators.  Potential predictor variables included Cataract Surgical 
Coverage (CSC) and prevalence of Uncorrected Refractive Errors (URE), extracted 
from the reports, as well as Gross Domestic Product (GDP) per capita, health 
expenditure per capita of the country across World Bank regions. Univariate and 
multivariate linear regression were used to investigate the correlation between 
potential predictor variables and the ratio. 
Results:  The results of 94 surveys from 43 counties showed that the ratio ranged from 
1.35 in Mozambique to 11.03 in India with a median value of 3.90. There was a 
significant regional variation of the ratio: approximately 7.0 in South Asia and 
approximately 3.0 in Sub-Saharan Africa (p<0.001). Univariate regression analysis 
showed that prevalence of URE, CSC (at 3/60, 6/60 and 6/18) for persons, logarithm 
of GDP per capita and logarithm of health expenditure per capita were significantly 
associated with the ratio. However, only prevalence of URE and CSC at 3/60 for 
persons were found to be statistically significant in multivariate regression analysis. 
Conclusion: There is a wide variation in the ratio of the prevalence of low vision to the 
prevalence of blindness.  Eye service indicators such as the prevalence of URE and 
CSC explain some of the variation across the regions.   
 
Keywords: rapid assessment of avoidable blindness, low vision, blindness, 
uncorrected refractive errors, cataract surgical coverage 
 
 
*Under supervision of Prof Susan Lewallen, Department of Ophthalmology, University of Cape Town
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INTRODUCTION  
There are 32.4 million blind and 191 million moderate and severe visually impaired 
people in the world.1 Worldwide, cataracts (33%) are the leading cause of blindness 
(Presenting Visual Acuity (PVA) of less than 3/60 in the better eye) followed by 
Uncorrected Refractive Error (URE) (21%) and macular degeneration (7%). 
Uncorrected Refractive Error (53%) is the leading cause of Moderate and Severe 
Visual Impairment (MSVI) (PVA of less than 6/18 but not less than 3/60 in the better 
eye) followed by cataracts (18%) and macular degeneration (2%). Moderate and 
Severe Visual Impairment combined is known as low vision. These data come from a 
systematic review which included 48 population-based unpublished studies, 4 
government reports and 44 Rapid Assessment of Cataract Surgical Services (RACSS) 
and Rapid Assessment of Avoidable Blindness (RAAB) surveys.  
 
Until 2005, Rapid Assessment of Cataract Surgical Services surveys were 
conducted to provide information on prevalence of blindness due to cataracts, cataract 
surgical coverage, visual outcomes after cataract surgery and barriers for uptake of 
cataract surgery in the age group 50 years and above.2 The RACSS uses a modified 
Expanded Programme on Immunization (EPI) random walk sampling method which 
divides the study area into clusters with equal numbers of households and people in 
each household based on recent census data. Then the clusters are randomly 
selected.3, 4 The second stage of the sampling is the selection of individual households 
within the cluster by spinning a bottle at the street crossing. All the eligible participants 
of the selected households go through the standard eye examination. 
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Selection of households using a spun bottle was considered to lead to potential 
selection bias (favoring households nearest the centre of the village). To avoid this 
compact segment sampling was introduced with the RAAB methodology.  The RAAB 
methodology provides information on prevalence of visual impairment due to cataracts 
but also includes causes of vision loss such as URE, glaucoma, trachoma, 
onchocerciasis, and corneal scarring. RAAB uses a compact segment sampling 
method whereby the study area is divided into clusters of, usually, 50 people. The 
clusters to be sampled are randomly selected then divided into many segments with 
equal numbers of households and people in each segment. A segment is randomly 
selected from each cluster and all the households of the segment are included for the 
survey.  The standard RAAB protocol is used to examine all eligible people in that 
segment.  
 
The RAAB repository website provides a safe storage of RACSS and RAAB 
survey data conducted worldwide so that researchers, in theory, have access to the  
data.5 This is to try to increase use of the data.  Full reports of the surveys are either 
available from the repository or may be requested from the Principal Investigator (PI). 
The PI or the donor agency determines what information to put in the repository and 
what information to provide on request. This makes it difficult to generalise the findings 
globally merely based on the repository results.  
 
When the RAAB survey results are compared for different countries it can be 
seen that the prevalences of blindness and low vision vary widely. For instance a 
recent systematic review in Sub-Saharan Africa (SSA), which included 17 surveys of 
15 countries, found that the prevalence of blindness was between 0.1% in Uganda 
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and 9% in Eritea.6 In addition, the prevalence of low vision varied from 1.6% in Gambia 
and Uganda to 17.1% in Ghana. Similarly a review study conducted using RACSS and 
RAAB surveys of 12 Latin American countries found that the prevalence of blindness 
(PVA<3/60 in the better eye) was between 1.3% in Buenos Aires, Argentina and 4.2% 
(PVA <6/60 in the better eye) in Venezuela.7 
 
Since the data on prevalence of low vision is not available for many regions, it 
is estimated based on the prevalence of blindness. Prevalence of low vision is 
estimated to be 3 to 4 times the prevalence of blindness in adults.8 But there is a wide 
variation in the ratio of prevalence of low vision to prevalence of blindness across 
geographical regions worldwide.  For example the ratio of prevalences of low vision to 
blindness was found between 1.3 and 6.3 in 27 RAAB surveys of 19 Sub-Saharan 
African countries.9 
 
To the best of our knowledge, there is no description of the variation of the 
proportion of low vision to blindness in countries other than Sub-Saharan Africa, nor 
is there any exploration into the reasons for the variation. URE is the most common 
cause of low vision but is not a common cause of blindness.10 Since the prevalence of 
refractive error varies tremendously in various parts of the world,10-12 it is possible that 
variation in URE would explain the variation in the ratio of prevalence of low vision to 
prevalence of blindness.  It is also known that the prevalence of blindness differs with 
the country’s economy. For instance it is estimated that the prevalence of blindness is 
more than 1% in very low income countries whereas it is 0.75%, 0.50% and 0.25% in 
low, middle and high income countries respectively.8  Therefore it might be that either 
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or both of these factors correlates with the ratio of the prevalence of low vision to 
blindness and helps explain the variation. 
 
Describing the variation in the ratio of low vision to blindness across a large 
number of surveys from a wide geographical region and examining whether it is 
associated with prevalence of URE and indicators of a country’s economy would 
enhance understanding of epidemiology of visual impairment and blindness globally. 
Furthermore it could possibly provide useful information for predicting the impact of 
targeting URE needs. Therefore this study aimed to determine the magnitude and the 
determinants of the ratio between prevalences of low vision to blindness globally, 
using data from RAAB surveys.   
 
MATERIALS AND METHODS 
Study Design 
The study design was observational analytical. A retrospective secondary analysis 
was performed of 94 RAAB surveys, covering 257,757 people of 50 years and above 
from 43 counties between 2003 and 2015.  
 
Examination and Data Collection 
The detailed methodology for the RAAB survey was previously published,  a brief 
description of the methodology is mentioned in this paper.13 Visual Acuity (VA) of 
eligible participants is measured using a Snellen tumbling E chart, which has optotype 
of size 6/18 and 6/60 on either side. Pinhole vision is assessed if the person cannot 
see 6/18 in either eye. If the VA improves to at least 6/18 with pinhole, the eye is 
recorded to have refractive error. The crystalline lens is examined using both torch 
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and distant direct ophthalmoscopy in a shaded or dark room. All eyes with VA less 
than 6/18 with the available correction are examined with a direct ophthalmoscope to 
assess the cause of vision loss. Portable slit lamp may be used to assess the vision 
loss if it is available. Only the primary cause of blindness or visual impairment is 
recorded as the diagnosis for each eye. If the two eyes have different diagnoses, then 
the cause of vision loss for the person is recorded as the diagnosis considered most 
easily treated.   
 
All the 217 RAAB surveys listed in the RAAB repository (as of 10 February 
2016) were assessed using the inclusion criteria checklist guidelines (Appendix 1). 
Those surveys which had the reports in the repository and met the criteria were 
identified and selected for the study. Reports of surveys which were eligible for the 
study but missing in the repository were requested from the PIs through the request 
link in the repository. Finally,  surveys which were not listed in the repository but were 
known from previous publications using RAAB methodology14  and for which data were 
available (KwaZulu-Natal, South Africa-2009 and White Nile, Sennar, Northen, 
Kodorfan of Sudan-2010)  were also included in the study. 
 
Inclusion and Exclusion Criteria 
The inclusion criteria for the study were: the survey should have used the standard 
RAAB methodology, the coverage of the survey had to be at least 80% of the sample 
size calculated and the survey should have a downloadable standard RAAB report in 
the repository OR the report obtained through the request procedure with permission 
from the PIs. The exclusion criteria for the study were: the surveys conducted using 
RACSS or custom methodology and the surveys with missing data on prevalence of 
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low vision and blindness AND/OR probable explanatory variables. In addition, the 
surveys for which the permission to use the data could not be obtained from the PIs 
were excluded from the study.  
  
Statistical Analysis 
Data analysis was performed using the statistical software STATA 11 (Stata Corp. 
College Station, Texas). The ratio of unadjusted prevalence of low vision to unadjusted 
prevalence of blindness was considered as the outcome variable. Continuous 
variables were described using mean (standard deviation) or median (inter-quartile 
range) based on the normality. Normality of the variables was checked using the 
histogram and Shapiro-Wilk test. The associations between the ratio and the potential 
explanatory variables were assessed using Spearman’s rank correlation coefficient. 
The variation of the ratio in different regions was assessed using analysis of variances 
(ANOVA). When the variances were significantly different to one another (checked 
using Bartlett’s test), Kruskal-Wallis test was used. Univariate regression analysis was 
performed keeping ratio as an outcome variable and the other variables individually 
as explanatory variables. Multiple linear regression was fitted using the ratio as the 
outcome variable, and the explanatory variables which had p value of below 0.2 in the 
univariate analysis. Explanatory variables which had high collinearity were excluded 
from the multivariate analysis. Logarithm transformation (base 10) was performed for 
the highly skewed variables and the not-normally distributed outcome variable. The 
description and source of the variables is shown in Table 1. Probability (p) value below 
0.05 was considered statistically significant for two-sided tests. 
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Table 1. Description and source of the variables. 
Variables Description and source 
Prevalence of 
unadjusted LV 
Continuous variable, obtained from Sample report (Table 2) 
Prevalence of 
unadjusted BL 
Continuous variable, obtained from Sample report (Table 2) 
Ratio  Ratio of the prevalence of unadjusted LV to the prevalence of 
unadjusted BL 
Prevalence of URE Continuous variable, calculated as the number of people Blind, 
SVI and MVI due to URE  divided by the total number of  
people examined in the survey; obtained from Sample report 
(Tables 1, 4, 6 & 8) 
CSC 3/60 (Persons) Continuous variable, obtained from Sample report (Table 12)  
CSC 6/60 (Persons) Continuous variable, obtained from Sample report (Table 12) 
CSC 6/18 (Persons) Continuous variable, obtained from  Sample report (Table 12) 
WB region Polytomous variable; 6 regions based on WB classification15 
GDP per capita Gross domestic product per capita in US dollars by country for 
closest year of survey, obtained from World Bank report16 
Health expenditure 
per capita 
Health expenditure per capita in US dollars by country for 
closest year of survey, obtained from World Bank report17 
 
LV, Low Vision; BL, Blindness; URE, Uncorrected Refractive Error; MVI, Moderate 
Visual Impairment; SVI, Severe Visual Impairment; CSC, Cataract Surgical Coverage; 
WB, World Bank; GDP, Gross Domestic Product; USD, United States Dollars. 
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Ethical Considerations 
All the RAAB surveys, which were included in the study, obtained verbal consent from 
the participants before enrolling them in the survey. Each individual survey was 
conducted in accordance with the tenants of the Declaration of Helsinki. The ethical 
approval of the study protocol was obtained from the Human Research Ethics 
Committee, University of Cape Town (Approval number 069/2016). 
 
RESULTS 
Surveys included in the Study 
Out of 217 surveys in the repository, 156 were RAAB surveys. The sources of 94 
surveys, which were included in the study, are presented in Table 2. A survey from 
Negros, Philippines (2005) was excluded from the study because of low coverage 
(76%). The largest number of surveys were from Vietnam (16) followed by China (10) 
and Nepal (10).  Figure 1 presents the sources of the 94 surveys. The description of 
the 94 surveys is shown in Tables 7, 8, 9, 10 and 11 of Appendix 6. 
 
Description of the Variables 
The ratio of the prevalences of low vision to blindness was the lowest in Nampula, 
Mozambique (1.35 times) and it was the highest in Gujarat, India (11.03 times). The 
mean (standard deviation), range, median and interquartile range of the ratio and 
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Obtained from the 
Trainer with permission 


















RAAB, Rapid Assessment of Avoidable Blindness; DR, Diabetic Retinopathy, 
RACSS, Rapid Assessment of Cataract Surgical Services; PI, Principal Investigator 
 
Figure 1. Sources of the included surveys. 
RAAB Surveys (156) 
Reports available in 
the Repository (66) 
Reports received 
through request link in 
the repository (10) 
RAAB Surveys included in the Study (94) 
Request sent to PIs for the reports (90) 
Obtained from the 
Trainer with 
permission from the 
PIs but NOT listed 
in the repository (8) 
Surveys in the Repository (217) 
RACSS Surveys (43) 
RAAB+DR Surveys (11) 
Custom Surveys (7) 
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Table 2. Description of the variables. 
Variables Survey, N Mean (SD) Range Median (IQR) 
Prevalence of 
unadjusted low vision a 
94 11.85 (4.82) 2.30; 26.10 11.90 (7.90; 14.80) 
Prevalence of 
unadjusted Blindness a 
94 3.33 (2.27) 0.70; 10.84 2.65 (1.70; 4.0) 
Ratio a 94 4.51 (2.32) 1.35;11.03 3.90 (3.06;5.38) 
Prevalence of URE (%)a 86 4.50 (2.25) 1.38;14.66 4.03 (3.03;5.14) 
CSC 3/60 (Persons) (%) 94 64.58 (19.09)  10.10;100 64 (52.10;80.60) 
CSC 6/60 (Persons) (%) 94 55.40 (19.77)  8.20;98 55.25 (39.60;69.60) 
CSC 6/18 (Persons) (%)a 94 37.77 (17.78) 6.40;96.70 36.1 (25.50;48.80) 






Health expenditure per 






a Data not normally distributed (Shapiro Wilk test p<0.05). 
SD, Standard Deviation; IQR, Interquartile Range; URE, Uncorrected Refractive Error; 







                                                                        
Part C: Journal Manuscript 14 
Association between the Ratio and Other Variables 
The association between the ratio and other potential explanatory variables is shown 
in Table 3. There was a statistically significant association between the ratio and the 
prevalence of URE (rs=0.26, p=0.01). 
 
Table 3. Correlation between the ratio and the explanatory variables. 
 Survey, N Spearman’s 
coefficient (rs) 
p value 
Prevalence of URE 86 0.26 0.01 
CSC 3/60  94 0.52 <0.001 
CSC 6/60  94 0.41 <0.001 
CSC 6/18  94 0.28 <0.01 
GDP per capita 94 0.21 0.03 
Health expenditure per capita 93 0.19 0.05 
 
URE, Uncorrected Refractive Error; LV, Low Vision; CSC, Cataract Surgical 
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Distribution of the Ratio across the Regions  
The distribution of the ratio across the regions is shown in Table 4. The mean 
(standard deviation) ratio was found to be the highest in South Asia, 6.96 (2.86) 
followed by Latin America and Caribbean, 6.22 (2.63). There was a statistically 
significant difference in variation of ratio across the regions (Kruskal-Wallis test, 
χ²=31.15, p<0.001). 
 





Range Median (IQR) 








Latin America and 
Caribbean a 
16 (17.02) 6.02 (2.55) 
 
3.41;10.85 5.28  
(4.07;6.87) 




Middle East and North 
Africa 




Total 94 (100)    
 
a Data not normally distributed (Shapiro Wilk test p<0.05). 
WB, World Bank; SD, Standard Deviation; IQR, Interquartile Range. 
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Univariate Regression Analysis 
The results of the univariate regression analysis are presented in Table 5. 
 
Table 5. Univariate analysis of the logarithm of the ratio with other variables. 
Log10 of Ratio Survey, 
N 
Univariate regression 
coefficients (95% CI) 
R2 adj. 
(%) 
p value RMSE 
Prevalence of URE (%) 86 0.047 (0.0006; 0.094) 3.47 0.04 0.49 
Log10 CSC 3/60 94 0.70 (0.45;0.95) 25.11 <0.001 0.43 
Log10 CSC 6/60  94 1.18 (0.67;1.69) 17.98 <0.001 0.45 
Log10 CSC 6/18  94 0.67 (0.22;1.13) 7.73 0.004 0.48 
Log10 GDP per capita 94 0.25 (0.045;0.47) 4.93 0.01 0.49 
Log10 Health 
expenditure per capita 
93 0.23 (0.20;0.45) 3.89 0.03 0.49 
 
CI, Confidence Intervals; URE, Uncorrected Refractive Error; R2 adj, Adjusted 
coefficient of determination; RMSE: Root Mean Square Error; CSC, Cataract Surgical 
Coverage; GDP, Gross Domestic Product. 
 
Multivariate Regression Analysis 
Logarithm of CSC at 6/60 and logarithm of CSC at 6/18 were found to be statistically 
significantly correlated with logarithm of CSC at 3/60 (Pearson’s coefficient=0.97, 
p<0.001 and spearman’s coefficient=0.91 and p<0.001 respectively). Hence only CSC 
at 3/60 was included in the multivariate model. Similarly logarithm of GDP per capita 
was found to be statistically significantly correlated with logarithm of health 
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expenditure per capita (spearman’s coefficient=0.94, p<0.001). Hence, logarithm of 
GDP per capita was excluded from the model. 
 
 East Asia and Pacific was used as the reference region because it had the 
largest number of surveys contributing to the study. In addition, the average mean 
ratio of East Asia and Pacific region was the closest to the overall mean ratio of all the 
surveys. The coefficients with p values of the multivariate regression model are 
presented in Table 6. 
 
Interpretation of the Multivariate Regression Model 
Prevalence of URE and CSC at 3/60 explained the variability of the ratio of prevalence 
of low vision to prevalence of blindness. The effect was statistically significant (p=0.03 
and 0.002 respectively). The effect of health expenditure per capita on the ratio was 
not statistically significant (p=0.60). On average, keeping prevalence of URE and CSC 
at 3/60 constant, South Asia and Latin America and Caribbean had higher logarithms 
of the ratio between prevalences of low vision and blindness compared to East Asia 
and Pacific. However the effect was not statistically significant (p=0.07 for each). Sub-
Saharan Africa and Middle East and North Africa had lower logarithms of the ratio 
compared to East Asia and Pacific. The effect for Sub-Saharan Africa was statistically 
significant (p=0.002) but was not statistically significant for Middle East and North 
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Table 6. Coefficients of the multivariate regression model with p values. 
Explanatory Variables Coefficients (95% CI) p value 
Prevalence of URE (%) 0.04 (0.003;0.077) 0.03 
Log10 CSC 3/60 0.43 (0.17;0.67) 0.002 
Log10 Health expenditure per capita -0.06 (-0.33;0.19) 0.60 
Sub-Saharan Africa -0.33 (-0.54;-0.12) 0.002 
Latin America and Caribbean 0.26 (-0.28;0.55) 0.07 
Middle East and North Africa -0.36(-0.81;0.08) 0.11 
South Asia 0.28 (-0.029;0.59) 0.07 
Survey, N=85, p<0.001, R2 adj. =45.54, RMSE=0.37. 
 
Reference region: East Asia and Pacific. 
CI, Confidence Intervals, URE, Uncorrected Refractive Error; R2 adj, Adjusted 
coefficient of determination; RMSE: Root Mean Square Error; CSC, Cataract Surgical 
Coverage. 
 
A quantile-quantile (between predicted values and the outcome variable) plot 
and residual versus predicted values plot were checked to assess the linear regression 
assumption. Both plots were found fairly null which showed that the assumptions for 
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DISCUSSION 
In this analysis we have documented and described the wide variation in the ratio of 
prevalences between low vision and blindness found in RAAB surveys from around 
the world and explored several factors which might be correlated with the variation. 
 
We expected that the magnitude of Uncorrected Refractive Error might be 
important in explaining the variation. It is known from a previous systematic review in 
Sub-Saharan Africa that URE is responsible for low vision rather than blindness10 
although this has not been assessed in other regions. We also expected that the 
cataract surgical coverage could affect the ratio since places where cataracts are not 
operated on, even at very advanced levels might be expected to have relatively higher 
prevalences of blindness. We also considered a few basic socioeconomic indicators 
such as GDP per capita and health expenditure per capita. 
 
We included a total of 94 RAAB studies from 43 countries.  All World Bank 
regions were represented although not evenly;  36%, 30%, 17%, 13% and 4% of 
studies  were from East Asia and Pacific,  Sub-Saharan Africa, Latin America and 
Caribbean, South Asia, and  Middle East and North African regions respectively.  It 
was interesting to learn that the RAAB Repository provides access for less than 50% 
(66/156) of the RAAB studies listed. 
 
The ratio between unadjusted prevalences of low vision to blindness varied 
from 1.35 in Mozambique to 11.03 in India. There was a big variation of the ratio across 
the regions and it was statistically significant (Kruskal-Wallis test, χ²=28.23, p<0.001).  
The highest mean ratio was found in South Asia (approximately 7.0, Range: 3.37 to 
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11.03) and the lowest ratio was found in Sub-Saharan Africa (approximately 3.0, 
Range: 1.35 to 6.16) (Table 4). The ratio was found to be in a similar range in Sub-
Saharan Africa by a previous study9, which relied on almost the same data as this one. 
However a 2002 study conducted using 43 studies from 15 World Health Organization 
subregions for all-ages found the range of the ratio to be 2.4 to 5.8, which is narrower 
than our finding.18 
 
The prevalence of URE varied widely in our study, between 1.38% in Ninh 
Thuan, Vietnam-2007 and 14.66% in Ngozi & Kayanza, Burundi-2012. (Table 2). The 
large variation of prevalence of URE is in agreement with other literature. A review 
conducted in 2008 found that the prevalence of visual impairment caused by URE in 
people aged 50 years and above was between 2% and 5% in most regions of the 
world but nearly 10% in China and 20% in India and the other South East Asian 
countries (Bangladesh, Nepal, Pakistan).19 In addition, as in our hypothesis, 
prevalence of URE was found to be positively associated with the ratio (rs=0.26, 
p=0.01). 
 
There was a big difference in Cataract Surgical Coverage among the study 
surveys. The CSC at 3/60 for persons was 10.1% in the 2011 study in Nampula, 
Mozambique and 100% in Central Malaysia in the 2014 study. Similarly the CSC at 
6/60 and 6/18 were the lowest in Nampula, Mozambique (8.2% and 6.4% respectively) 
and the highest in Central, Malaysia (98% and 96.7% respectively). The variation of 
CSC across the surveys reflects the varying level of service provision in the survey 
sites.  
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The univariate regression analysis showed that variation in the ratio of 
prevalences between low vision and blindness could potentially be explained by 
prevalence of URE, CSC by persons at 3/60, 6/60 and 6/18, logarithm of GDP per 
capita and logarithm of health expenditure per capita across the WB regions (Table 
5). We used variable CSC at 3/60, but not CSC at 6/60 and CSC at 6/18 for multiple 
regression, because blindness is defined on the basis of Presenting Visual Acuity of 
3/60 or worse in the better eye. Similarly, we believed that health expenditure per 
capita is a better reflection of a country’s wealth spent on eye care than GDP per 
capita. We therefore included health expenditure per capita in the multiple regression 
analysis. In multivariate regression analysis, prevalence of URE and CSC at 3/60 were 
found to be associated with the ratio of prevalences between low vision and blindness 
across the regions (Table 6). However logarithm of health expenditure was not 
statistically significantly associated with the ratio.  
 
Our study has some limitations. We have included only RAAB surveys so our 
study is likely to have the same limitations as the RAAB methodology. RAAB does not 
provide an estimate of the prevalence of refractive error itself; instead it provides an 
estimate of URE. These may be very similar in low income countries with limited eye 
services.  Another limitation is the potential variability in methodology among surveys. 
In RAAB, URE is supposed to be reserved as a diagnosis for eyes that achieve normal 
vision (6/18) with a pinhole; however, sometimes URE is used as the diagnosis in eyes 
that do not fulfill this criteria (Lewallen’s unpublished data). It would have been 
preferable to use the ratio of age and sex adjusted prevalences of low vison and 
blindness in our study. The RAAB studies provide prevalence of URE only for the 
sample population so we could not use age-adjusted ratio for our analysis. It would be 
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interesting to do further analysis on gender adjusted prevalences of low vision and 
blindness. 
 
To the best of our knowledge this is the first large study to assess the magnitude 
and determinants of the variation of ratio between prevalences of low vision and 
blindness using RAAB studies globally.  It appears that the prevalence of URE as well 
as CSC affect this ratio and explain the wide variations that have been reported. When 
making estimates of the magnitude of people with impaired vision in the world, it is 
important to realise that the ratio of low vision to blindness will vary widely and not to 
assume that it will always be 3 to 4 as was suggested in the early stages of the VISION 
2020 initiative when the first attempts to estimate this were made.8 This study helps 
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APPENDIX 6: SUPPLEMENTARY TABLE 
Description of included surveys in the study is shown in Tables 7, 8, 9, 10 and 11. 
 
Table 7. Surveys from East Asia and Pacific region. 
 
(Continues on next page) 
Country Province / 
Region 





Cambodia - - 2007 6000 98.4 Repository 
China Yunnan Lancang 2012 2550 94.8 Repository 
China Yunnan Jianchuan 2012 2100 95.6 Repository 
China Sichuan Mianning 2011 2850 98.8 Repository 
China Sichuan Dechang 2011 1749 98.5 Repository 
China Inner Mongolia Shangdu 2010 2000 98.8 Repository 
China Inner Mongolia Tuoketuo 2010 2098 96.4 Repository 
China Yunnan Kunming 2008 2760 93.8 Repository 
China Jiangxi Xingan 2007 4000 95.9 Repository 
China Jiangxi Gao'an 2007 5000 94 Repository 
China Jiangxi Wanzai 2007 3000 95.4 Repository 
Malaysia Eastern - 2014 2500 98 Obtained on 
request 
Malaysia Northen - 2014 2500 96.7 Obtained on 
request 
Malaysia Sabah - 2014 2500 95.4 Obtained on 
request 
Malaysia Sarawahk - 2014 2500 95.4 Obtained on  
request 
Malaysia Southern - 2014 2500 94.8 Obtained on 
request 
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Country Province / 
Region 





Malaysia Central - 2014 2500 91.3 Obtained on 
request 
Philippines Antique - 2006 3842 82.7 Repository 
Vietnam Vung Tau - 2007 1800 92.5 Repository 
Vietnam Tien Giang - 2007 1799 95.7 Repository 
Vietnam Thai Nguyen - 2007 1800 97.2 Repository 
Vietnam Phu Tho - 2007 1800 100 Repository 
Vietnam Ninh Thuan - 2007 1800 98.7 Repository 
Vietnam Nghe An - 2007 1800 94.1 Repository 
Vietnam Lao Cai - 2007 1800 98.2  Repository 
Vietnam Hue - 2007 1800 98.1 Repository 
Vietnam Ho Chi Minh - 2007 1800 97.2 Repository 
Vietnam Ha Tay - 2007 1799 95.4 Repository 
Vietnam Hai Phong - 2007 1800 100 Repository 
Vietnam Gia Lai - 2007 1798 96.7 Repository 
Vietnam Can Tho - 2007 1800 99.3 Repository 
Vietnam Binh Phuoc - 2007 1800 98.8 Repository 
Vietnam Binh Dinh - 2007 1800 96.7 Repository 
Vietnam Bac Ninh - 2007 1800 96.7 Repository 
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Table 8. Surveys from Sub-Saharan Africa region. 
 
(Continues to next page) 
 
Country Province / 
Region 





Botswana - - 2013 3310 93.3 Obtained on 
request 
Burundi Ngozi & 
Kayanza 




- - 2015 3560 93.8 Obtained on 
request 
Eritrea National - 2008 3163 95.9 Obtained on 
request 
Guinea Bissau National - 2010 2900 99 Obtained on 
request 
Kenya Coast Kwale 2011 3250 96.1 Repository 
Kenya Southern 
Nyanza 
- 2010 2603 98.6 Obtained on 
request 
Kenya Rift Valley Kericho 2007 2546 95 Repository 
Kenya Rift Valley Nakuru 2005 3750 92.7 Repository 
Madagascar Analamanga - 2015 3605 94.9 Obtained on 
request 
Madagascar Atsinanana - 2011 3157 87.7 Repository 
Malawi Southen Chiradzulu 2009 3583 95.7 Repository 
Mali Koulikoro - 2011 2226 96.8 Obtained on 
request 
Mozambique Sofala - 2012 3599 94.1 Repository 
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(Continued from previous page) 
 
 
Country Province / 
Region 





Mozambique Nampula - 2011 2954 96.9 Obtained on 
request 
Senegal Kaolack - 2010 2834 97.7 Obtained on 
request 
Senegal Fatick - 2010 2514 96.7 Obtained on 
request 
Sierra Leone National - 2011 2976 97.6 Obtained on 
request 
South Africa Kwazu-Natal INK 2009 1179 92.8 Obtained on 
request 
Sudan White Nile - 2010 2097 97.5 Obtained on 
request 
Sudan Sennar - 2010 1938 96.7 Obtained on 
request 
Sudan Northen - 2010 1952 95.3 Obtained on 
request 
Sudan Kodorfan - 2010 2032 94.5 Obtained on 
request 
Tanzania Kilimanjaro  2007 3597 95.5 Repository 
Tanzania Zanzibar - 2007 3160 98.8 Obtained on 
request 
Uganda Western Hoima 2013 3862 99.1 Repository 
Uganda Central Mubende 2012 3850 96.9 Repository 
Zambia Southern 
Province 
- 2010 3629 95 Obtained on 
request 
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Country Province / 
Region 





Argentina Buenos Aires Buenos Aires 2003 4600 93.5 Repository 
Brazil Sao Paulo Campinas 2003 2400 92.7 Repository 
Chile Bio Bio - 2006 3000 97.2 Repository 
Dominican 
Republic 
- - 2008 3995 96.9 Repository 
Ecuador National - 2009 4200 95.5 Repository 
El Salvador National   2011 3800 89.4 Repository 
Guatemala 4 states - 2004 4900 98.1 Repository 
Honduras National - 2013 3150 95.2 Repository 
Moldova National  2012 3885 98 Obtained on 
request 
Mexico Chipas Central, 
Highland & 
Frialesca 
2010 3250 86.8 Repository 
Mexico Nuevo Leon - 2005 3780 99.6 Repository 
Panama National - 2013 4200 98.2 Repository 
Paraguay National - 2011 3000 95.4 Repository 
Peru National - 2011 5000 97 Repository 
Suriname National - 2013 3000 93.5 Obtained on 
request 
Uruguay National - 2011 3950 94.3 Repository 
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Table 10. Surveys included from South Asia region. 
 
11. Surveys from Middle East and North Africa region. 
 
 
Country Province / 
Region 





Bangladesh Khulna Satkhira 2006 5295 91.9 Repository 
India Gujarat Surat 2011 2200 97.1 Obtained on 
request 
Nepal Rapti - 2010 2998 97.4 Repository 
Nepal Dhaulagiri - 2010 3000 99.7 Repository 
Nepal Sagarmatha - 2009 3050 95.5 Repository 
Nepal Mechi - 2009 3050 99.7 Repository 
Nepal Koshi - 2009 3050 94.9 Repository 
Nepal Bheri - 2009 3050 98.1 Repository 
Nepal Seti & 
Mahakali 
- 2008 2751 91.3 Repository 
Nepal Karnali - 2008 1197 97.8 Repository 
Nepal Janakpur - 2008 1800 94.7 Repository 
Nepal Bagmati - 2008 2050 93.1 Repository 
Country Province / 
Region 
District Year Sample 
Size 
Coverage (%) Source 
Iran Tehran  Varamin 2009 3000 94 Repository 
Palestine  National - 2008 3800 94.2 Repository 
Yemen Al Amran - 2009 1948 91.8 Repository 
Yemen Lahj - 2009 1948 94.3 Obtained on 
request 
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APPENDIX 7: SUPPLEMENTARY FIGURES 
 
Figures 2 and 3 shows the diagnostic plots of the multivariate regression model. 
 
 




Figure 3. Plot between residuals and fitted values 
